CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 82 filers reported holding CULLINAN ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,161,510 | +4.2% | 2,890,775 | +23.9% | 0.01% | +8.3% |
| Q2 2023 | $25,114,766 | +211.1% | 2,334,086 | +195.8% | 0.01% | +200.0% |
| Q1 2023 | $8,072,880 | -2.2% | 789,138 | +0.9% | 0.00% | 0.0% |
| Q4 2022 | $8,251,429 | -18.0% | 782,126 | -0.4% | 0.00% | -20.0% |
| Q3 2022 | $10,067,000 | +0.8% | 785,219 | +0.8% | 0.01% | 0.0% |
| Q2 2022 | $9,988,000 | +22.6% | 779,082 | +0.2% | 0.01% | +66.7% |
| Q1 2022 | $8,144,000 | -31.9% | 777,880 | +0.4% | 0.00% | -25.0% |
| Q4 2021 | $11,951,000 | -31.8% | 774,534 | -0.2% | 0.00% | -42.9% |
| Q3 2021 | $17,524,000 | -12.5% | 776,406 | -0.1% | 0.01% | -12.5% |
| Q2 2021 | $20,021,000 | -1.6% | 777,498 | +59.2% | 0.01% | 0.0% |
| Q1 2021 | $20,348,000 | – | 488,308 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
| CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
| Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
| TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
| BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
| Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
| Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
| BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
| Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
| DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |